DICE
|Dice Molecules Holdings LLC
NASDAQ
USD
|%
Current Price
Change
(%)
P/E Ratio
Dividend Yield
Market Cap
2.27B
Volume
Open
Previous Close
52-Week High
52-Week Low
About Dice Molecules Holdings LLC
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE is designed to discover selective oral small molecules to modulate protein-protein interactions as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17) that is a validated drug target implicat...
Sector:Healthcare
Industry:Biotechnology
CEO:Dr. J. Kevin Judice Ph.D.
Employees:71
Headquarters:South San Francisco, USA
Website:www.dicemolecules.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions